Form 4: Artivion General Counsel Sells Over 8,700 Shares in Pre-Arranged Transaction

Jean F. Holloway, SVP and General Counsel of Artivion, Inc. (AORT), reported the sale of 8,748 shares of common stock at $29 per share, executed under a Rule 10b5-1 trading plan.

Summary

• Jean F. Holloway, the Senior Vice President and General Counsel of Artivion, Inc. (AORT), reported a transaction involving the company's common stock.
• On May 27, 2025, Ms. Holloway disposed of 8,748 shares of Artivion common stock.
• The shares were sold at a price of $29 per share.
• This transaction was conducted under a Rule 10b5-1 trading plan, indicating it was a pre-arranged sale.
• Following this transaction, Ms. Holloway beneficially owns 178,510 shares of Artivion common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly negative. While an insider sale can be perceived negatively, the disclosure that it was executed under a Rule 10b5-1 plan mitigates concerns, as it suggests a pre-planned liquidity event rather than a reactive sale based on new adverse information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct stake in the company.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

• The filing includes the signature of Jean F. Holloway, confirming the reported transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide broader industry context or trends. It reflects an individual executive's liquidity management or compensation strategy within the medical device or healthcare sector.

Stakeholder Impact

• Shareholders: May view the insider sale as a routine liquidity event, especially given the 10b5-1 plan, but some might interpret it as a slight reduction in insider confidence, potentially influencing short-term sentiment.

Key Dates

Recommendation

Keywords

Artivion, AORT, Insider Trading, Form 4, SEC Filing, Stock Sale, Executive Compensation, Rule 10b5-1, Common Stock